These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 10702799)
21. Secretory carcinoma of the breast: a genetically defined carcinoma entity. Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913 [TBL] [Abstract][Full Text] [Related]
22. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996 [TBL] [Abstract][Full Text] [Related]
23. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907 [TBL] [Abstract][Full Text] [Related]
24. TEL/AML1 shows dominant-negative effects over TEL as well as AML1. Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275 [TBL] [Abstract][Full Text] [Related]
25. Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). Beverloo HB; Panagopoulos I; Isaksson M; van Wering E; van Drunen E; de Klein A; Johansson B; Slater R Cancer Res; 2001 Jul; 61(14):5374-7. PubMed ID: 11454678 [TBL] [Abstract][Full Text] [Related]
26. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
27. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation. Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677 [TBL] [Abstract][Full Text] [Related]
28. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Okuda K; Golub TR; Gilliland DG; Griffin JD Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688 [TBL] [Abstract][Full Text] [Related]
29. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase. Mancini A; Niedenthal R; Joos H; Koch A; Trouliaris S; Niemann H; Tamura T Oncogene; 1997 Sep; 15(13):1565-72. PubMed ID: 9380408 [TBL] [Abstract][Full Text] [Related]
30. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG. Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468 [TBL] [Abstract][Full Text] [Related]
31. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Chakrabarti SR; Nucifora G Biochem Biophys Res Commun; 1999 Nov; 264(3):871-7. PubMed ID: 10544023 [TBL] [Abstract][Full Text] [Related]
32. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616 [TBL] [Abstract][Full Text] [Related]
33. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816 [TBL] [Abstract][Full Text] [Related]
34. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. Law SF; Zhang YZ; Fashena SJ; Toby G; Estojak J; Golemis EA Exp Cell Res; 1999 Oct; 252(1):224-35. PubMed ID: 10502414 [TBL] [Abstract][Full Text] [Related]
35. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of glutathione biosynthesis in NIH3T3 cells transformed with the ETV6-NTRK3 gene fusion. Kim SJ; Kim HG; Lim HW; Park EH; Lim CJ Mol Cells; 2005 Feb; 19(1):131-6. PubMed ID: 15750350 [TBL] [Abstract][Full Text] [Related]
37. ETV6: a versatile player in leukemogenesis. Bohlander SK Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831 [TBL] [Abstract][Full Text] [Related]
38. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs. Matuoka K; Miki H; Takahashi K; Takenawa T Biochem Biophys Res Commun; 1997 Oct; 239(2):488-92. PubMed ID: 9344857 [TBL] [Abstract][Full Text] [Related]
39. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis. Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377 [TBL] [Abstract][Full Text] [Related]
40. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways. Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]